Strides Pharma Science Limited — Board Meeting, 18-05-2026: Outcome of Board Meeting

Strides Pharma's board has proposed Deloitte Haskins & Sells LLP as the new Statutory Auditors for a five-year term. This change, replacing B S R & Co. LLP, will take effect post-2027 AGM, subject to shareholder consent.